STOCK TITAN

Phantom stock grant increases Zimmer Biomet (NYSE: ZBH) director units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Kolli Sreelakshmi reported acquisition or exercise transactions in this Form 4 filing.

Zimmer Biomet Holdings, Inc. director Sreelakshmi Kolli received a grant of 180.323 phantom stock units as a compensation award under the company’s deferred compensation plan for non-employee directors. Following this grant, she holds a total of 6,842.604 phantom stock units, which will be settled in common stock within sixty days after her board service ends.

Positive

  • None.

Negative

  • None.
Insider Kolli Sreelakshmi
Role null
Type Security Shares Price Value
Grant/Award Phantom Stock Units 180.323 $0.00 --
Holdings After Transaction: Phantom Stock Units — 6,842.604 shares (Direct, null)
Footnotes (1)
  1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. The Conversion or Exercise Price of Derivative Security is 1-for-1. Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
Phantom stock units granted 180.323 units Grant to director on 2026-06-30
Total phantom units after grant 6,842.604 units Holdings following transaction
Conversion ratio 1-for-1 Each unit settled as one common share
Reported conversion/exercise price $86.6500 Conversion or exercise price field for derivative security
Underlying common shares 180.323 shares Underlying Zimmer Biomet common stock
Phantom Stock Units financial
"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."
Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.
Deferred Compensation Plan for Non-Employee Directors financial
"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."
Conversion or Exercise Price financial
"The Conversion or Exercise Price of Derivative Security is 1-for-1."
Company common stock financial
"Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kolli Sreelakshmi

(Last)(First)(Middle)
345 E. MAIN STREET

(Street)
WARSAW INDIANA 46580

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Phantom Stock Units(1)$86.65(2)06/30/2026A180.323 (3) (3)Common Stock180.323$06,842.604D
Explanation of Responses:
1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
2. The Conversion or Exercise Price of Derivative Security is 1-for-1.
3. Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
/s/ Matthew R. St. Louis, Attorney-in-Fact for Sreelakshmi Kolli (power of attorney previously filed)07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did ZIMMER BIOMET HOLDINGS, INC. (ZBH) report for Sreelakshmi Kolli?

Zimmer Biomet reported that director Sreelakshmi Kolli received 180.323 phantom stock units as a compensation award. These units were granted under the Deferred Compensation Plan for Non-Employee Directors and are linked 1-for-1 to shares of company common stock.

How many phantom stock units does ZBH director Sreelakshmi Kolli hold after this Form 4?

After this grant, Sreelakshmi Kolli holds 6,842.604 phantom stock units. This total reflects her accumulated awards under the deferred compensation plan and represents units tied on a 1-for-1 basis to Zimmer Biomet common stock.

When will the phantom stock units granted to ZBH director Sreelakshmi Kolli be settled?

The phantom stock units will be settled in shares of Zimmer Biomet common stock within sixty days after Sreelakshmi Kolli’s service as a director ends. Settlement timing is therefore tied directly to the cessation of her board service.

What does the 1-for-1 conversion or exercise price mean for ZBH phantom stock units?

A 1-for-1 conversion means each phantom stock unit corresponds to one share of Zimmer Biomet common stock upon settlement. This links the value of the deferred units directly to the company’s stock, aligning director compensation with shareholder outcomes.

Are the phantom stock units reported on ZBH’s Form 4 an open-market purchase or a grant?

The phantom stock units are a grant, not an open-market purchase. The Form 4 lists transaction code A, indicating a grant, award or other acquisition under a company plan rather than a trade executed in the public market.